# Longterm-Evaluation of Vitelene® Against Standard

> **NCT01713062** · — · ACTIVE_NOT_RECRUITING · sponsor: **Aesculap AG** · enrollment: 400 (actual)

## Conditions studied

- Osteoarthritis, Hip
- Arthritis

## Interventions

- **DEVICE:** Vitelene
- **DEVICE:** XLPE

## Key facts

- **NCT ID:** NCT01713062
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-01
- **Primary completion:** 2027-04
- **Final completion:** 2030-06
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01713062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01713062, "Longterm-Evaluation of Vitelene® Against Standard". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01713062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*